OPRD1 抗体 (pSer363) (Biotin)
Quick Overview for OPRD1 抗体 (pSer363) (Biotin) (ABIN2690259)
抗原
See all OPRD1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- pSer363
-
特异性
- This phosphorylation site is homologous in the listed cross reactive species at the specified location.
-
交叉反应
- 人, 小鼠, 大鼠
-
预测反应
- Cow,Chicken,Rabbit
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human OPRD1 around the phosphorylation site of TP(p-S)DG
-
亚型
- IgG
-
-
-
-
应用备注
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C for 12 months.
-
有效期
- 12 months
-
-
- OPRD1 (Opioid Receptor, delta 1 (OPRD1))
-
别名
- OPRD1
-
背景
-
Synonyms: OPRD, Delta-type opioid receptor, D-OR-1, DOR-1, OPRD1
Background: G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
-
基因ID
- 4985
-
UniProt
- P41143
-
途径
- Protein targeting to Nucleus
抗原
-